
Validea's guru fundamental report rates UnitedHealth Group (UNH) at 77% using the Martin Zweig Growth Investor model, which targets companies with accelerating earnings and sales, reasonable valuations, and low debt. While UNH, a large-cap health insurer, passes several key growth and valuation metrics, it notably fails tests for revenue growth in relation to EPS growth and earnings growth consistency over the past several quarters, positioning it just below the 80% threshold for 'some interest' despite the Zweig model's strong historical performance.
UnitedHealth Group (UNH) scores a 77% rating based on Validea's Martin Zweig Growth Investor model, positioning it just below the 80% threshold that typically indicates model interest. The analysis reveals a company with several strong growth attributes, including a passing P/E ratio, robust sales growth, positive earnings persistence, and favorable insider transaction signals. Notably, UNH demonstrates current earnings momentum, with current quarter EPS growth surpassing that of the prior three quarters and the same quarter one year ago. However, the model also flags significant points of caution. The company fails the test for revenue growth relative to EPS growth, suggesting that bottom-line expansion may not be fully supported by top-line gains. Furthermore, the model indicates a lack of consistent earnings growth over the past several quarters and notes that the current quarter's EPS growth rate, while accelerating, does not exceed the company's longer-term historical growth rate. This presents a mixed fundamental picture of a large-cap insurer with recent positive momentum but underlying inconsistencies that temper the overall growth narrative.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment